Hos patienter med moderat nedsat nyrefunktion, der oplever generende bivirkninger, bør dosis nedsættes til 1 mg 1 gang dagligt.
For patients with moderate renal impairment who experience adverse events that are not tolerable, dosing may be reduced to 1 mg once daily.